The Journal of Experimental Medicine
ELISpot, FluoroSpot and ELISA kits from Mabtech
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published 25 February 2002. doi:10.1084/jem.20011751
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 335K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yamazaki, T.
Right arrow Articles by Kurosaki, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamazaki, T.
Right arrow Articles by Kurosaki, T.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
© Rockefeller University Press, 0022-1007/2002/3/535/ $5.00
The Journal of Experimental Medicine, Volume 195, Number 5, March 4, 2002 535-545


Original Article

Essential Immunoregulatory Role for BCAP in B Cell Development and Function

Tetsuo Yamazaki1, Kiyoshi Takeda3, Kumiko Gotoh1,2, Hiroshi Takeshima4, Shizuo Akira3 and Tomohiro Kurosaki1,2

1 Department of Molecular Genetics, Institute for Liver Research, Kansai Medical University
2 Laboratory for Lymphocyte Differentiation, RIKEN Research Center for Allergy and Immunology, 10-15 Fumizono-cho, Moriguchi, Osaka 570-8506, Japan
3 Department of Host Defense, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka 565-0871, Japan
4 Division of Cell Biology, Institute of Life Science, Kurume University, Kurume, Fukuoka 839-0861, Japan

Address correspondence to Tomohiro Kurosaki, Department of Molecular Genetics, Institute for Liver Research, 10-15 Fumizono-cho, Moriguchi, Osaka 570-8506, Japan. Phone: 81-6-6993-9445; Fax: 81-6-6994-6099; E-mail: kurosaki{at}mxr.mesh.ne.jp

BCAP was recently cloned as a binding molecule to phosphoinositide 3-kinase (PI3K). To investigate the role of BCAP, mutant mice deficient in BCAP were generated. While BCAP-deficient mice are viable, they have decreased numbers of mature B cells and B1 B cell deficiency. The mice produce lower titers of serum immunoglobulin (Ig)M and IgG3, and mount attenuated responses to T cell–independent type II antigen. Upon B cell receptor cross-linking, BCAP-deficient B cells exhibit reduced Ca2+ mobilization and poor proliferative responses. These findings demonstrate that BCAP plays a pivotal immunoregulatory role in B cell development and humoral immune responses.

Key Words: mice • knockout • antigen receptor • phospholipase C-{gamma} • calcium


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS